Gabriele Gugliotta
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola(IT)Istituto di Ematologia di Bologna(IT)University of Bologna(IT)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia(2009)210 cited
- → Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?(2016)180 cited
- → Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors(2009)173 cited
- → A review of the European LeukemiaNet recommendations for the management of CML(2015)167 cited
- → Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain(2013)162 cited
- → The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview(2019)136 cited